Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine.
about
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Checkpoint kinase inhibitor AZ ...... arcinoma cells to gemcitabine.
@en
Checkpoint kinase inhibitor AZ ...... arcinoma cells to gemcitabine.
@nl
type
label
Checkpoint kinase inhibitor AZ ...... arcinoma cells to gemcitabine.
@en
Checkpoint kinase inhibitor AZ ...... arcinoma cells to gemcitabine.
@nl
prefLabel
Checkpoint kinase inhibitor AZ ...... arcinoma cells to gemcitabine.
@en
Checkpoint kinase inhibitor AZ ...... arcinoma cells to gemcitabine.
@nl
P2093
P2860
P50
P1476
Checkpoint kinase inhibitor AZ ...... arcinoma cells to gemcitabine.
@en
P2093
Jindrich Cinatl
Makoto Isono
Maria Pinkerneil
Michèle J Hoffmann
P2860
P2888
P356
10.1186/S13046-016-0473-1
P577
2017-01-03T00:00:00Z
P6179
1012191446